Report of the Skin Research Workgroups from the GRAPPA 2018 Annual Meeting

J Rheumatol Suppl. 2019 Jun;95:28-32. doi: 10.3899/jrheum.190124.

Abstract

At the 2018 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), the International Dermatology Outcome Measures (IDEOM) Psoriasis Working Group presented an overview of its efforts to enhance clinical care and research in both the clinical setting as well as in clinical trials for psoriasis. First, the group discussed the results of a Delphi survey conducted in collaboration with the American Academy of Dermatology to agree on a unique physician-reported global assessment to measure the quality of care delivered to patients with psoriasis and other chronic inflammatory dermatoses. Second, the group summarized its efforts to select outcome measures for "PsA symptoms" and "treatment satisfaction," 2 of the domains of the psoriasis core domain set that were established by IDEOM. Finally, the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN) presented an update on its clinical, educational, and research missions to foster the development of combined clinics for psoriatic disease, increase disease awareness, and accelerate management.

Keywords: GRAPPA; IDEOM; PSORIASIS; PSORIASIS OUTCOMES; PSORIATIC ARTHRITIS; TREATMENT SATISFACTION.

MeSH terms

  • Arthritis, Psoriatic / drug therapy*
  • Arthritis, Psoriatic / pathology
  • Dermatology
  • Humans
  • Outcome Assessment, Health Care
  • Patient Satisfaction*
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Rheumatology
  • Skin / pathology*